Alphabet Hit By Another Wave Of AI Departures: Report
Alphabet Hit By Another Wave Of AI Departures: Report
SEC 8-K filings, insider trades, FDA approvals, Federal Reserve statements, and market-moving events — AI-curated, updated every 60 seconds.
Alphabet Hit By Another Wave Of AI Departures: Report
Nike Shares In Focus As Company Names New CFO, Analysts Weigh In Ahead Of Q4 Earnings
'Boeing Wins Jet Deal From China Southern Valued at $3.62 Billion' - Bloomberg
Johnson & Johnson's TECVAYLI Receives Committee For Medicinal Products For Human Use Approval Recommendation To Treat Relapsed Or Refractory Multiple Myeloma
Dan Ives Says Microsoft And Meta Are Being Treated Like 'Bear Market' Stocks
This Nike Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday
Oppenheimer Maintains Outperform on Nike, Lowers Price Target to $60
What's Going On With Intel Stock Friday?
Magnificent Seven’s Black June Triggers $1 Billion Exodus From MAGS ETF
JPMorgan Chase Stock Pauses After Hitting New All-Time High: What Investors Need To Know
Guggenheim Maintains Buy on Johnson & Johnson, Raises Price Target to $270
The Memory Oligopoly: How Micron And 6 Other Names Now Set The Price For The AI Race
Nike Analyst Turns Bearish As Recovery Takes Longer Than Expected
'Apple’s Touch MacBook to Use M5 Pro and Max Chips, With M7 Models to Follow' - Bloomberg
Reported June 25, 2026: 'OpenAI Will Stagger GPT 5.6 Release Following Trump Administration Request For Review' - CNBC
Truist Securities Maintains Hold on JPMorgan Chase, Raises Price Target to $344
Johnson & Johnson Announces Additional Data On IMAAVY Throughout 12 Abstracts At European Academy Of Neurology 2026 Congress; Participants Demonstrated Greater Reductions In MG-ADL…
OpenAI IPO Reportedly Delayed To 2027: 'There's No Rational Argument' For $1 Trillion Valuation, Says Gary Marcus
Deutsche Bank Maintains Hold on Nike, Lowers Price Target to $43
CDC Raises Its Response Level To Congo Ebola Outbreak To Level 1 Activation, Its Highest Level; Says Risk Of Ebola Spreading In The U.S. Remains Low